Home>Topics>Stocks>EnteroMedics

EnteroMedics ETRM

  1. All
  2. Commentary
  3. Stock Reports
  4. Headlines
    1. Medtech Shifts From High Gear Into Overdrive: Canaccord's William Plovanic

      Headlines

      Wed, 20 Aug 2014

      By Life Sciences Report : Rapid growth in the medical device industry and changes in the regulatory environment have propelled valuations in the medtech sector to the high end of the range. But new technologies create new investment opportunities. In this interview with The Life Sciences Report ,

    2. EnteroMedics' ( ETRM ) CEO Mark Knudson on Q2 2014 Results - Earnings Call Transcript

      Headlines

      Thu, 7 Aug 2014

      EnteroMedics , Inc. (NASDAQ: ETRM ) Q2 2014 Earnings Conference Call August 7, 2014 11:00 a.m ..... business update. As a reminder, this conference call, as well as EnteroMedics ’ SEC filings and Web site at enteromedics .com, Complete Story

    3. More on EnteroMedics Q2 results

      Headlines

      Thu, 7 Aug 2014

      EnteroMedics (NASDAQ: ETRM ) Q2 results : Revenue: $0; Operating Expenses: $7.4M (+21.1%); Operating Loss: ($7.4M) (-21.1%); Net

    4. EnteroMedics misses by $0.01

      Headlines

      Thu, 7 Aug 2014

      EnteroMedics (NASDAQ: ETRM ): Q2 EPS of -$0.11 misses by $0.01 . Press Release Post your comment!

    5. EnteroMedics shares jump as FDA panel supports obesity device

      Headlines

      Wed, 18 Jun 2014

      June 18 (Reuters) - EnteroMedics Inc's shares jumped about 37 percent in premarket trading on Wednesday, a day after an advisory panel to the U.S. Food and Drug Administration voted in favor of the...

    6. Dropping Coverage of EnteroMedics

      Commentary

      Fri, 5 Jul 2013

      We are no longer providing equity research on EnteroMedics ETRM . We provide broad coverage of more than 1,700 companies across more than 140 industries and adjust our coverage as necessary based on client demand and investor interest.

    7. New Morningstar Analyst Report - EnteroMedics , Inc.

      Stock Reports

      Thu, 21 Feb 2013

      will be a significant obstacle for EnteroMedics . With limited reimbursement, Maestro ..... neurostimulation that leads to weight loss. EnteroMedics ' key patent that covers electrical ..... million-16 million patients available to EnteroMedics .Even though Maestro's effectiveness

    8. EnteroMedics Moves Closer to Unblinding Its Pivotal Study for Maestro

      Commentary

      Wed, 24 Oct 2012

      EnteroMedics ETRM posted third-quarter results that ..... value estimate unchanged. Although EnteroMedics has begun to roll out its Maestro system ..... until after 2017. In the meantime, EnteroMedics burned through another $5.6 million

    9. EnteroMedics Enters the Home Stretch With Maestro

      Commentary

      Tue, 7 Aug 2012

      EntroMedics ETRM has made significant progress ..... valuation shortly. Now that EnteroMedics has shored up its cash ..... full year 2012. While EnteroMedics began its launch in Kuwait ..... 2013, especially after EnteroMedics has submitted its last

    10. After Stabilizing its Finances, EnteroMedics Looks Forward to Commercializing Maestro

      Commentary

      Tue, 24 Apr 2012

      Now that EnteroMedics ETRM has made significant progress on ..... Australia. For the first time, EnteroMedics booked product revenue, following ..... distributor. Perhaps most important, EnteroMedics has put financing in place to keep

    « Prev12Next »
    Content Partners